FDA.reportPublic FDA data

Application 018667

Type
NDA
Sponsor
HOSPIRA

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001FUROSEMIDEFUROSEMIDEINJECTABLE;INJECTION10MG/MLNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0409-6102FurosemideFUROSEMIDEHospira, Inc.NDACurrent
0409-6102FurosemideFUROSEMIDEHospira, Inc.NDACurrent
0409-6102FUROSEMIDEfurosemideHospira, Inc.NDACurrent
0409-6102FurosemideFUROSEMIDEHospira, Inc.NDACurrent
0409-6102FurosemideFUROSEMIDEHospira, Inc.NDACurrent
0409-6102FUROSEMIDEfurosemideHospira, Inc.NDACurrent
0409-6102FUROSEMIDEfurosemideHospira, Inc.NDACurrent
0409-6102FurosemideFUROSEMIDEHospira, Inc.NDACurrent
0409-6102FurosemideFUROSEMIDEHospira, Inc.NDACurrent
0409-6102FurosemideFUROSEMIDEHospira, Inc.NDACurrent
0409-6102FUROSEMIDEfurosemideHospira, Inc.NDACurrent
0409-6102FUROSEMIDEfurosemideHospira, Inc.NDACurrent
51662-1226FUROSEMIDEFUROSEMIDEHF Acquisition Co LLC, DBA HealthFirstNDACurrent
51662-1226FUROSEMIDEFUROSEMIDEHF Acquisition Co LLC, DBA HealthFirstNDACurrent
51662-1226FUROSEMIDEFUROSEMIDEHF Acquisition Co LLC, DBA HealthFirstNDACurrent
51662-1226FUROSEMIDEFUROSEMIDEHF Acquisition Co LLC, DBA HealthFirstNDACurrent
51662-1226FUROSEMIDEFUROSEMIDEHF Acquisition Co LLC, DBA HealthFirstNDACurrent
51662-1227FUROSEMIDEFUROSEMIDEHF Acquisition Co LLC, DBA HealthFirstNDACurrent
51662-1227FUROSEMIDEFUROSEMIDEHF Acquisition Co LLC, DBA HealthFirstNDACurrent
51662-1227FUROSEMIDEFUROSEMIDEHF Acquisition Co LLC, DBA HealthFirstNDACurrent
51662-1227FUROSEMIDEFUROSEMIDEHF Acquisition Co LLC, DBA HealthFirstNDACurrent
51662-1227FUROSEMIDEFUROSEMIDEHF Acquisition Co LLC, DBA HealthFirstNDACurrent
51662-1227FUROSEMIDEFUROSEMIDEHF Acquisition Co LLC, DBA HealthFirstNDACurrent
51662-1336FUROSEMIDEFUROSEMIDEHF Acquisition Co LLC, DBA HealthFirstNDACurrent
51662-1336FUROSEMIDEFUROSEMIDEHF Acquisition Co LLC, DBA HealthFirstNDACurrent
51662-1336FUROSEMIDEFUROSEMIDEHF Acquisition Co LLC, DBA HealthFirstNDACurrent
51662-1336FUROSEMIDEFUROSEMIDEHF Acquisition Co LLC, DBA HealthFirstNDACurrent
52584-102FurosemideFurosemideGeneral Injectables & Vaccines, IncNDACurrent
52584-102FurosemideFurosemideGeneral Injectables & Vaccines, IncNDACurrent
52584-102FurosemideFurosemideGeneral Injectables & Vaccines, IncNDACurrent
55154-2364FurosemideFurosemideCardinal HealthNDA AUTHORIZED GENERICCurrent
55154-2364FurosemideFurosemideCardinal HealthNDA AUTHORIZED GENERICCurrent
55154-2364FurosemideFurosemideCardinal Health 107, LLCNDA AUTHORIZED GENERICCurrent
55154-2364FurosemideFurosemideCardinal HealthNDA AUTHORIZED GENERICCurrent
55154-2365FurosemideFUROSEMIDECardinal HealthNDACurrent
55154-2365FurosemideFurosemideCardinal HealthNDA AUTHORIZED GENERICCurrent
55154-2365FurosemideFUROSEMIDECardinal HealthNDACurrent
55154-2365FurosemideFUROSEMIDECardinal Health 107, LLCNDACurrent
55154-2365FurosemideFUROSEMIDECardinal HealthNDACurrent
55154-2391FurosemideFurosemideCardinal HealthNDA AUTHORIZED Current
55154-7830FUROSEMIDEfurosemideCardinal HealthNDACurrent
55154-7830FUROSEMIDEfurosemideCardinal HealthNDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
79814SUPPL 2024-10-03
79807SUPPL 2024-10-03
73727SUPPL 2023-03-10
71991SUPPL2022-09-01
71989SUPPL2022-09-01
45530SUPPL2016-10-12
45413SUPPL2016-09-29